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doi:10.1016/j.ejvs.2010.01.012Abstract Objective: A prototype ready-to-fenestrate stent graft (RFSG) was designed with
a fixed scallop, and eight potential fenestrations allowing for variation in the position of each
renal artery (RA) relative to the superior mesenteric artery (SMA). We aimed to determine the
proportion of juxtarenal aneurysms treatable using this potentially ‘off-the-shelf’ device.
Methods: A total of 439 consecutive orders for custom-made devices were analysed, and posi-
tions for potential fenestrations in the RFSG were determined, based on the most frequent
anatomical target vessel variations: a fixed SMA scallop 12 mm deep at 12:00, RA fenestrations
at 9:15, 10:15 (target within the range 8:45e10:45), 2:15 and 3:15 (target within the range
1:45e3:45), each either 19 or 28 mm from the graft edge (GE); (within the range 15e
32 mm), and 6  8 mm in diameter. Proximal diameters of 24, 26, 28, 30, 32 and 36 mm were
chosen.
Results: Of the 439 plans, 372 standard juxtarenal (SJR) cases, defined by the inclusion of
a scallop and 0, 1 or 2 small fenestrations (12%, 13% and 75% of the cases, respectively) were
identified and used to test the applicability of the model. Mean CP (clock position) for right RA
was 9:30, for the left RA 3:00, being a mean of 21  5 and 22  5 mm, respectively from the
GE. RA CP was within the RFSG range in 86% (right) and 88% (left) of the cases, with 96% and
98%, respectively, within the allowable distance from the GE. A total of 81% of all SJR cases
were potentially treatable using the RFSG model.
Conclusions: An RFSG device would allow for the treatment of the majority of juxtarenal aortic
aneurysms, which currently require custom-made devices.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.44 20 73809409.
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432 B.J. Manning et al.An inadequate length of the infrarenal landing zone is the
most frequent reason for unsuitability for repair of
abdominal aortic aneurysms by endovascular means,1 and
most manufacturers recommend a minimum infrarenal
landing zone of 10e15 mm to protect against proximal
endoleak. Fenestrated stent grafts (FSGs) have been
developed to enable extension of the haemostatic seal
zone to the visceral aortic segment, maintaining perfusion
to target vessels by means of covered stents placed through
the fenestrations, and flared at the luminal interface.2,3 A
description of the planning and deployment of FSGs has
been published.4 For the renal arteries (RAs), fenestrations
of the size 6 mm  6 mm or 6 mm  8 mm (referred to as
small fenestrations) are usually sufficient and are placed in
the fabric between the struts of the stents, which allows
them to be stented. Larger arteries, such as the superior
mesenteric artery (SMA) and coeliac arteries, require larger
fenestrations (at least 8 mm  8 mm in size) and it is not
always possible to make these strut free. In most cases,
large fenestrations are not required as an adequate seal
can be achieved with only small fenestrations for RAs.
Device manufacturing constraints require small fenestra-
tions to be at least 15 mm from the graft edge (GE).
Proximity of the SMA to RAs will nearly always require
a ‘scallop’ or crescent-shaped defect to be built into the
top of the fabric (10 mm wide and 6e12 mm deep) to
ensure that the SMA is not compromised. Therefore, the
most commonly applied design comprises of a scallop and,
at most, two small fenestrations within the fenestrated
component.
FSGs have allowed pararenal aortic aneurysms to be
treated successfully by endovascular means, with accept-
able early and mid-term results.5e10 The disadvantage of
FSGs is that they are designed on an individual patient
basis, and custom-made to accommodate varying positions
of the renal and mesenteric vessels, as well as varying
diameters of the aneurysm neck. The cost of such bespoke
devices, as well as the time required for their manufacture,
restricts the widespread adoption of this minimally invasive
treatment, which is not a realistic option for patients
needing urgent intervention in any circumstance.
For these reasons, an ‘off-the-shelf’ aortic stent graft,
which would allow for the incorporation of fenestrations, is
desirable and necessary if more patients with pararenal
aneurysms are to be offered endovascular repair. Whilst the
stock required to allow treatment of all pararenal aneurysms
wouldbeprohibitively extensive,wehypothesise that among
those patients with juxtarenal aortic aneurysms (JRAAs),
patterns of distribution and separation of the visceral vessels
exist, and stent graft technology has evolved such as to allow
a small number of devices appropriately treat most JRAAs.
We propose that a single stent graft could contain several
‘potential fenestrations’ in the sealing stents, one or two of
which could be converted to true fenestrations, according to
patient anatomy, close to the time of treatment. In the
present study, we examine the structural variation and
patterns of fenestration distribution in previously ordered
custom-made FSGs, to design a ‘ready-to-fenestrate stent
graft’ (RFSG), incorporating potential fenestrations. We aim
to determine the proportion of JRAAs (those previously
treated with FSGs) that would be amenable to treatment
with the proposed device.Methods
Anonymous specifications for a consecutive series of 439
custom-made devices (CMDs) planned and manufactured
for individual patients with pararenal aneurysms were
obtained from the device manufacturer (William A Cook,
Australia PTY Ltd). Specifications for manufactured devices
were chosen rather than device-order forms to ensure that
only one data set for each patient was included. Data
analysis was specific to the aortic neck, as currently avail-
able off-the-shelf devices are available to achieve seal in
the iliac arteries in the majority of patients with aortic
aneurysms. Data subject to analysis included the diameter
of the proximal sealing stents, the number of fenestrations
(large, 8  8 mm; and small, 6  8 mm), the clock
position (CP) of each of these fenestrations (taking 12:00 as
being anterior orthogonal to the long axis of the aneurysmal
neck, as is the convention) and the distance of these
fenestrations (the centre of the fenestration) from the
proximal GE. As most FSGs also include a scallop to incor-
porate the visceral vessel adjacent to the uppermost part
of the sealing stent (usually the SMA where two fenestra-
tions for the RAs are planned), the position and depth of
each scallop was also included in the analysis. A standard
fenestrated stent graft (SFSG) for the purpose of this study
is defined as a stent graft planned to treat a JRAA which
incorporates one small fenestration each for each RA, and
a scallop for the SMA, one small fenestration and a scallop,
or no fenestration but a single scallop. We excluded from
the analysis those previously ordered CMDs that did not
conform to this pattern.
Some redundancy exists in the current protocols
employed in planning FSGs for JRAAs. All target vessels are
assigned a CP based on arbitrarily defining the most ventral
point of the aortic neck in the orthogonal plane as 12:00.
Furthermore, the depth of the scallop is variable up to
12 mm for an SFSG, even though the origin of the coeliac
artery is unlikely to be less than 12 mm from the bottom of
a scallop planned to accommodate the SMA. For the
purpose of applying the data on previously ordered CMDs to
the design of an RFSG, the following adjustments were
made to the raw data received:
1. All scallops were assigned a CP of 12:00 and CPs for RAs
were adjusted accordingly. Therefore, a plan that
included a scallop at 12:30 and small fenestrations for RAs
at 3:45 and 10:00 would now be modified as having
a scallopat 12:00 and renal fenestrations at 3:15 and9:30.
2. All scallops were taken as being 12 mm deep. Therefore,
a plan that included an SMA scallop 10 mm deep and RA
fenestrations 18 mm and 22 mm for the GE would now be
modified to include an SMA scallop 12 mm deep and RA
fenestrations 20 mm and 24 mm for the GE.
To extract an RFSG model from previously submitted
graft plans, an error margin is assumed based on the
authors’ experience of planning and placing FSGs and also
on technical advances, which allow for access to and
stenting of target vessels, which in turn might not be
exactly aligned with the centre of the fenestrations.
Therefore, an error margin of 30 min was assumed for CP
and 4 mm from the centre of the planned fenestration.
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planned RA positions allowed for a calculation of the
optimal positioning of ‘potential’ 6  8 mm small fenes-
trations in the RFSG model. We then applied the series of
order specifications for SFSGs to the proposed RFSG model
to determine the proportions of cases that would poten-
tially be treatable by this design.
Results
Of the 439plans for CMDs, 67wereexcluded fromtheanalysis
owing to non-standard requests, including large fenestra-
tions (21%), plans requesting two scallops (21%), plans
without scallops (55%) and those in which the small fenes-
tration was at the same level as the scallop (3%). The
remaining 372 plans were adjusted to place the scallop
12 mm deep at the 12:00 position. A total of 75% of plans
requested a scallop and two small fenestrations, 13%
a scallop and a single small fenestration and 12% a scallop
without fenestrations. The mean diameter of grafts
required, according to theplans,was 30 3.5mm(range24e
36 mm), with 66% of orders requesting grafts of at least
30 mm in diameter.
Mean CP for the left RA was 3:00  55 min and for the
right RA 9:30  40 min. The mean distance from the GE was
22  5 mm and 21  5 mm, respectively (Fig. 1). Based on
these distributions, an RFSG was planned with eight
potential fenestrations: two in the 9:15 position, two at
10:15, two at 2:15 and two at 3:15. Four of these fenes-
trations are placed 19 mm from the GE and four 28 mm from
the GE (Fig. 2). With one such graft each for diametersFigure 1 (a,b). Anatomical variation in the position of renal arte
tions of the right and left renal arteries as calculated relative to the
on the Stent Graft. (c,d) Distribution of the renal artery fenestra
fenestrations to the edge of the graft.24, 26, 28, 30, 32 and 36 mm (the presently available range
of sizes for CMDs), a maximal number of JRAAs would be
accounted for with a total of six stent grafts. Although we
do not present data regarding the length of the fenestrated
component, it is envisaged that all of the proposed RFSGs
would taper to 22 mm, and a further bifurcated device of
a single size would then be used to bridge to standard iliac
limbs.
A prototype graft was built using two specially widened
Gianturco stents provided to us by the device manufacturer
(William Cook Medical Ltd.), previously tested for use in the
thoracic aorta and of radial strength comparable to stents
used in standard infrarenal devices. Between adjacent
stents, sufficient room was available for eight potential
fenestrations (four on each side) in the positions already
planned (Fig. 2).
We tested the hypothesis and compared the compati-
bility of the received plans with the RFSG on which they are
based. We found that of the 306 fenestrations for the left
RA, 271 (86%) were within the CP range 1:45e3:45 and 293
(96%) were within the range of 15e32 mm from the GE. Of
the 302 fenestrations for the right RA, 266 (88%) were
within the range 8:45e10:45 and 295 (98%) were within the
range of 15e32 mm from the GE. Overall, 81% of all planned
cases were treatable using the RFSG model.
Discussion
Custom-made stent grafts for the treatment of JRAA contain
fenestrations and scallops positioned precisely according to
the measurements made using three-dimensional computedries calculated from previously planned FSGs. The clock posi-
SMA scallop, the position of which is taken as being 12 o’clock
tions, with dots representing distance from the centre of the
Figure 2 Suggested RFSG design with a cluster of 4 potential
fenestrations for each renal artery and a fixed scallop for the
SMA. Note the extra-wide Gianturco Stents.
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possible to ‘cut holes’ in the deployed non-FSGs according to
such measurements and then reload them on the delivery
system at the time of the procedure,11 this is not practical
for several reasons. First, deploying and reloading stent
grafts, and particularly complex devices, including
diameter-reducing wires, requires considerable technical
skill and an in-depth device knowledge. Furthermore, it is
technically difficult to create and accurately place the
fenestrations, which require radio-opaque markers to allow
correct device orientation once delivered, and also require
a reinforced rim to prevent fabric tearing and allow for over-
dilatation or flaring of stents to target vessels. In the present
study, we introduce the concept of the RFSG, which is
a device containing eight ‘potential’ fenestrations and
a single double-width (20 mm) scallop. The most important
finding of this analysis is that 81% of previously ordered FSGs,
for juxtarenal aneuryms, would be treatable based on
a stock of only six RFSG devices.
Several applications of this concept are possible. The
most immediately applicable practical improvement would
be for such devices to be appropriately fenestrated and
loaded at short notice by manufacturers, avoiding the
delayed and additional cost associated with current prac-
tice of building the stent graft to order, once the plans
have been received and approved. A more attractive
solution would be the ‘off-the-shelf’ devices. The use of
the preloaded wires through fenestrations has previously
been applied to FSG devices (unpublished experience) and
would facilitate the conversion of potential fenestrationsto actual fenestrations, as well as sheath placement
adjacent to the target vessel. In such cases, the standard
FSG design is modified by replacing the solid central
obturator that serves the purpose of an attachment point
for the distal end of the graft, and the top-cap retriever
with a thin wall tube, through which two 0.020-inch wires
run from the hub of the delivery system through the stent
graft out through each fenestration, attached to the
proximal edge of the graft by sutures, which can be
released by means of an additional trigger wire. This
facilitates passage of a sheath to or through the fenes-
tration, providing stability whilst target vessel catheter-
isation takes place, and avoiding the use of a large sheath
in the contralateral groin. We propose that, in the RFSG
model, each potential fenestration is preloaded with
a 0.014-inch guide wire from the hub of the delivery
system, through the shaft, through the potential fenes-
tration and attached to the top-cap. Once the patient
anatomy is examined and the required fenestrations are
chosen, the preloaded wires from the unwanted fenestra-
tions can be withdrawn along with the radio-opaque
markers around them, leaving the required fenestrations
only with preloaded wires and radio-opaque markers on
the stent graft. Although each potential fenestration
contains a reinforced rim, the fabric within this rim is only
perforated and punched out for the chosen fenestrations.
(An alternative solution is to replace the four distinct
potential fenestrations with a single large ‘fenestrable
zone’ covered with a nitinol mesh, which would act to
reinforce the fenestration by being compressed into a ring
as it is created.) The stent graft is then loaded or
sheathed, ready for delivery and deployment as for an
SFSG.
We excluded those devices that did not fit the pattern of
SFSGs for two reasons. First, most juxtarenal aneuryms
treated by means of FSGs require at most two small
fenestrations and a scallop, and it is unlikely that the more
complex cases requiring more than one fenestration, or
a combination of small and large fenestrations, could be
accommodated by an off-the-shelf device such as what we
are proposing. Second, by excluding atypical or more
complex FSGs from the analysis, we minimise the risk of
inaccuracy in assigning fenestrations to one of the RAs. In
other words, a small fenestration between 8:45 and 10:45,
in an SFSG, is very unlikely to be planned for anything other
than the right RA.
Although we propose an RFSG based on the analysis of
previously manufactured devices, we accept that our
model is crude and further testing will be required at
bench level and in animal models before it can be
considered for clinical use. We acknowledge that there are
some potential weaknesses in our hypothesis. The data
presented are based on the measurement of planned
CMDs, and not on measurements made directly from CTs.
However, owing to high costs of these devices and the time
required for manufacture, measurements for CMDs are
invariably repeatedly checked and re-measured against CT
reconstructions by experienced planners before final-
isation, making inaccuracy in the planning unlikely. The
RFSG model allows for a certain misalignment between
fenestrations and target vessels to a maximum of 4 mm
(from the centre of the fenestration to the centre of the
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30 min in CP. Our experience of planning for FSGs tells us
that significant inter-observer variability in measurements
of target vessel positions exists, at least to the scale
allowed for in the RFSG model, as the exact path that the
deployed SG will follow in an often-tortuous aorta is not
entirely predictable. The projected path of the centre line
about which measurements are made is always subject to
a degree of subjectivity and therefore an error margin. To
compensate for this, the currently available FSGs are
constrained by diameter-reducing wires even after initial
deployment, and this allows torque control and reposi-
tioning of the device to facilitate catheterisation of target
vessels, which may be offset from the fenestrations. The
addition of double diameter-reducing wires (reducing the
final diameter by 20% until completely deployed) improves
manoeuvrability even further, and is part of the RFSG
design.
Conclusions
Most juxtarenal abdominal aortic aneurysms, previously
treated with custom-made FSGs, show a pattern of distri-
bution of target vessels, which would be accommodated by
up to two of eight specifically positioned fenestrations, and
a single scallop. Application of these findings to develop an
RFSG would eliminate the need for most CMDs.
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